Sep 10, 2020 / 02:15PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Okay. Jim, I think we are now live. Good morning, everyone. This is Eric Coldwell. I'm Baird's Healthcare Services and Supply Chain analyst. It's our pleasure today to have Charles River with us. Of course, Jim Foster, Chairman, President and CEO; also in the background, Todd Spencer, VP of IR.
Jim, we're going to jump straight in. I think you might have a few prepared comments, and then we'll go straight to fireside chat.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Sure. Nice to be here. Eric, nice to see you.
We talked about some favorable trends in August when we had our second quarter call. And so I'm pleased to say that -- sorry, favorable trends in July. So I'm pleased to say that those trends continued in August. And we're pleased with how the third quarter is shaping up. And we expect that all segments will report improved growth in the third quarter. So we feel really good about
Charles River Laboratories International Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot